phenytoin / Generic mfg. |
ACTRN12624001326583: Efficacy of levetiracetam versus phenytoin in children with convulsive status epilepticus, Single blinded Randomized controlled trial |
|
|
| Not yet recruiting | N/A | 134 | | | Dr Hina Parvaiz- Medical Teaching Institute Lady Reading Hospital Peshawar | Status epilepticus | | | | |
NCT00004403: Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis |
|
|
| Completed | N/A | 120 | US | albendazole, dexamethasone, phenytoin | Johns Hopkins University | Epilepsy, Cysticercosis | | 03/02 | | |
NCT00333931: Pilot Trial of Neural Correlates of Response to Treatment of PTSD-Associated Impulsive Aggression |
|
|
| Unknown status | N/A | 12 | US | Phenytoin, Cognitive Behavioral Therapy | Michael E. DeBakey VA Medical Center, Dr. Thomas A. Kent, Dr. Stacey Holmes, Dr. Su Bailey, Dr. Mark Kunik, Dr. Melinda Stanley | Impulsive Aggression, Posttraumatic Stress Disorder | | | | |
NCT00226538: Prediction of Drug Interactions With CYP2C9 Substrates |
|
|
| Completed | N/A | 16 | RoW | Phenytoin, Rifampicin, Diclophenac, Fluconazole | Hadassah Medical Organization | Healthy Volunteers | | | | |
| Completed | N/A | 17 | US | Activated Charcoal, Charcoal | Emory University | Phenytoin Toxicity | 07/10 | 01/12 | | |
| Unknown status | N/A | 200 | RoW | | Rabin Medical Center | Primary Open Angle Glaucoma, Secondary Open Angle Glaucoma, Narrow-Angle Glaucomas, Normal Tension Glaucoma | 11/10 | 12/10 | | |
NCT01390909: Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database |
|
|
| Completed | N/A | 12386 | US | Anti-epileptic drug (AED), Mysoline® is a registered trademark of Valeant Pharmaceuticals, Neurotin® is registered trademark of Pfizer, Inc, Vimpat® is a registered trademark of UCB Pharma, Tegretol® is a registered trademark of Novartis Pharmaceuticals, Trileptal® is a registered trademark of Novartis Pharmaceuticals, Sabril® is a registered trademark of Lundbeck Inc, Felbatol® is a registered trademark of MedPointe, Topamax® is a registered trademark of Ortho-McNeill-Janssen Pharmaceuticals, Depakote® is a registered trademark of Abbott Laboratories, Zonegran® is a registered trademark of Dainippon Pharmaceutical C. Ltd., Gabatril® is a registered trademark of Cephalon, Keppra® is registered trademark of UCB Pharma, Zarontin® is a registered trademark of Pfizer, Lamictal® is a registered trademark of GlaxoSmithKline, Luminal® is a registered trademark of Abbott Laboratories, Dilantin® is a registered trademark of Pfizer, Lyrica is registered trademark of Pfizer | GlaxoSmithKline | Epilepsy | 01/11 | 01/11 | | |
| Terminated | N/A | 52 | NA | phenytoin, Dilantin, Cerebyx (a phenytoin pro-drug), valproate, Depakote, Depacon, levetiracetam, Keppra | Thomas Jefferson University, National Institute of Neurological Disorders and Stroke (NINDS) | Subarachnoid Hemorrhage | 06/12 | 06/12 | | |
NCT03269214: Use of Topical Phenytoin in Bisphosphonate-related Osteonecrosis of the Mandible |
|
|
| Completed | N/A | 20 | NA | Topical Phenytoin 5% | Shiraz University of Medical Sciences, Shahid Beheshti University of Medical Sciences | Osteonecrosis Due to Drugs, Jaw | 10/16 | 03/17 | | |
NCT03096522: Randomized Trial on the Effect of Topical Phenytoin on Healing After Fistulotomy |
|
|
| Unknown status | N/A | 38 | RoW | Phenytoin 2% spray, Healosol, Anal fistulotomy, Lay open of anal fistula tract | Mansoura University | Anal Fistula | 01/18 | 03/18 | | |
| Completed | N/A | 18 | US | Levetiracetam, Lacosamide, Phenytoin, Phenobarbital, Ketamine, Valproic Acid | University of Maryland, Baltimore | Acute Kidney Injury, Renal Insufficiency, Renal Failure, Pharmacokinetics | 12/19 | 12/19 | | |
| Unknown status | N/A | 1200 | RoW | Phenytoin single dose (300 mg) | Hadassah Medical Organization, United States - Israel Binational Science Foundation | Healthy | 12/20 | 12/20 | | |
| Unknown status | N/A | 600 | RoW | Warfarin, Phenytoin | Hadassah Medical Organization | Healthy | 12/20 | 12/20 | | |
NCT03712254: Phenytoin as Treatment for Acute Exacerbations of Trigeminal Neuralgia - a Prospective Systematic Study of 20 Patients |
|
|
| Completed | N/A | 15 | Europe | Fosphenytoin | Danish Headache Center | Trigeminal Neuralgia | 10/21 | 11/21 | | |
NCT06067412: Efficacy of Phenytoin vs Levetiracetam in Status Epilepticus at Institute of Child Health,Faisalabad |
|
|
| Completed | N/A | 70 | RoW | Levetiracetam, Phenytoin | Shaheed Zulfiqar Ali Bhutto Medical University | Status Epilepticus | 01/23 | 01/23 | | |
NCT05542589: Efficacy of Phenytoin Phonophoresis on Pressure Ulcer Healing |
|
|
| Completed | N/A | 40 | RoW | Phenytoin phonophoresis, Sham phenytoin phonophoresis | Cairo University | Pressure Ulcer | 02/23 | 02/23 | | |
| Recruiting | N/A | 80 | Europe | Ketamine, Perampanel, Any anti-epileptic and anesthetic therapy, excluding Ketamine and Perampanel, Levetiracetam, Valproate, Phenytoin, Lacosamide, Topiramate, Propofol, Midazolam, Thiopental | University of Milano Bicocca, Azienda Ospedaliera San Gerardo di Monza, Azienda Ospedaliero-Universitaria di Modena, Azienda Ospedaliera Universitaria Integrata Verona, Ospedale Centrale Bolzano, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Azienda Ospedaliero-Universitaria Careggi, Azienda Ospedaliero-Universitaria di Parma, Santa Chiara Hospital, Ospedale M. Bufalini Cesena, Azienda Ospedaliera Brotzu, Istituto Di Ricerche Farmacologiche Mario Negri | Status Epilepticus, Cardiac Arrest | 06/24 | 09/24 | | |
NCT06312254: Pharmacological Modulation of Peripheral Nerve Excitability |
|
|
| Not yet recruiting | N/A | 20 | Europe | Topical lidocaine 5%, Topical Phenytoin 10%, Topical Mepyramine 2%, Topical Placebo | Aalborg University | Peripheral Neuropathy | 02/25 | 08/25 | | |
| Recruiting | N/A | 1000 | Europe | Valproic acid, carbamazepine, phenobarbital, phenytoin, levetiracetam, lamotrigine, topiramate, oxcarbazepine, stiripentol, clobazam, brivaracétam, felbamate, lacosamide, rufinamide, gabapentine, pregabaline, sultiame, tiagabine, vigabatrine, mesuximide, primidone, perampanel, ethosuximide, zonisamide, cannabidiol, genetic polymorphisms | Assistance Publique - Hôpitaux de Paris | Epilepsy | 06/26 | 06/26 | | |
| Recruiting | N/A | 10400 | | carbamazepine ;sodium valproate ;lamotrigine ;topiramate ;oxcarbazepine ;levetiracetam ;gabapentin ;phenytoin ;phenobarbital ;clonazepam ;The antiepileptic drug 1 which will obtain marketing authorization in China in the future ;The antiepileptic drug 2 which will obtain marketing authorization in China in the future ;The antiepileptic drug 3 which will obtain marketing authorization in China in the future | The Department of Neurology, the First Affiliated Hospital of Wenzhou Medical University; The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical Association | epilepsy | | | | |